JeannieJirachatVisootsakMD
Pediatrics • Decatur, GADevelopmental-Behavioral Pediatrics, Hospitalist
Assistant Professor, Human Genetics, Emory University School of Medicine
Are you Dr. Visootsak?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
2165 N Decatur Rd
Decatur, GA 30033Phone+1 404-778-8590Fax+1 404-778-8562
Summary
- Dr. Jeannie Visootsak, MD is a board certified pediatrician in Decatur, Georgia. She is currently licensed to practice medicine in Georgia, New Jersey, and California. She is affiliated with Emory University Hospital and is an Assistant Professor at Emory University School of Medicine.
Education & Training
Charles R Drew UniversityResidency, Pediatrics, 1997 - 2000
David Geffen School of Medicine at UCLAClass of 1997
Certifications & Licensure
CA State Medical License 1999 - 2026
NJ State Medical License 2023 - 2025
GA State Medical License 2003 - 2019- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Developmental-Behavioral Pediatrics
Clinical Trials
- Dose-ranging Study of PRX-102 in Adult Fabry Disease Patients Start of enrollment: 2012 Oct 01
- A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome Start of enrollment: 2014 Jan 01
- Single Dose Pharmacokinetic (PK) Study Start of enrollment: 2017 Apr 03
Publications & Presentations
PubMed
- 20 citationsA Conceptual Model of Angelman Syndrome and Review of Relevant Clinical Outcomes Assessments (COAs)Joseph Grieco, Beverly Romero, Emuella Flood, Raquel Cabo, Jeannie Visootsak
The Patient. 2019-02-01 - 29 citationsClinical Development of Targeted Fragile X Syndrome Treatments: An Industry Perspective.Anna W. Lee, Pamela Ventola, Dejan B. Budimirovic, Elizabeth Berry-Kravis, Jeannie Visootsak
Brain Sciences. 2018-12-05 - 120 citationsArbaclofen in fragile X syndrome: results of phase 3 trials.Elizabeth Berry-Kravis, Randi J Hagerman, Jeannie Visootsak, Dejan B. Budimirovic, Walter E. Kaufmann
Journal of Neurodevelopmental Disorders. 2017-06-12
Press Mentions
- 18 Books to Celebrate down Syndrome Awareness MonthOctober 26th, 2020
